This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Xrad Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Michael Kastan: Innovator in Anti-Tumor Therapy
Introduction
Michael Kastan is a prominent inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of oncology through his innovative research and development of therapeutic compounds. His work focuses on advancing treatments for oncologic diseases, showcasing his commitment to improving patient outcomes.
Latest Patents
Michael Kastan holds a patent for "Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy." This patent includes compounds of the Formula (I), (II), and (III), as well as pharmaceutically acceptable salts thereof. The compounds are designed to be effective in treating oncologic diseases, providing new avenues for cancer therapy.
Career Highlights
Throughout his career, Michael has been associated with Xrad Therapeutics, Inc., where he has played a crucial role in the development of innovative cancer therapies. His expertise in the field has led to advancements that are vital for the treatment of various types of cancer.
Collaborations
Michael has collaborated with notable colleagues, including Jianmin Fu and Yaode Wang. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field of oncology.
Conclusion
Michael Kastan's contributions to anti-tumor therapy through his innovative patents and collaborations highlight his dedication to advancing cancer treatment. His work continues to inspire progress in the fight against oncologic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile